scholarly article | Q13442814 |
P356 | DOI | 10.1093/CARCIN/BGS127 |
P698 | PubMed publication ID | 22436611 |
P2093 | author name string | Sheng-Chu Kuo | |
Tur-Fu Huang | |||
Jin-Cherng Lien | |||
Shiu-Wen Huang | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
angiogenesis inhibitor | Q574834 | ||
P304 | page(s) | 1022-1030 | |
P577 | publication date | 2012-03-20 | |
P1433 | published in | Carcinogenesis | Q326022 |
P1476 | title | Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling | |
P478 | volume | 33 |
Q53788180 | Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models. |
Q28535457 | Anti-cancer activity of an osthole derivative, NBM-T-BMX-OS01: targeting vascular endothelial growth factor receptor signaling and angiogenesis |
Q52675240 | Antiangiogenic Effects of VH02, a Novel Urea Derivative: In Vitro and in Vivo Studies. |
Q53057689 | Antiangiogenic effects of cucurbitacin-I. |
Q37534643 | Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo |
Q37665271 | DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling |
Q38887615 | FGFs: crucial factors that regulate tumour initiation and progression. |
Q36026159 | Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine. |
Q33697011 | Identification of protein targets in cerebral endothelial cells for brain arteriovenous malformation (AVMs) molecular therapies |
Q34914220 | PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling |
Q39027159 | Synthesis, biological evaluation, and docking studies of new 2-furylbenzimidazoles as anti-angiogenic agents: part II. |
Q89697165 | Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles |
Q35238403 | WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1 |
Search more.